- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.12. | Centenarians - unlocking the secrets of living to 100 | ||
| 06.12. | Muna-GSK alliance to fast-track Alzheimer's disease treatments | ||
| 06.12. | FDA ARMAT status for Affimed and Artiva's lymphoma combo therapy | ||
| 05.12. | Dewpoint Therapeutics and Mitsubishi Tanabe link on ALS treatment | ||
| 05.12. | LEO Pharma's eczema cream gains MHRA marketing authorisation | ||
| 05.12. | FDA approves AstraZeneca's Imfinzi to treat LS-SCLC | ||
| 04.12. | CEO of UnitedHealthcare, Brian Thompson, shot dead in New York City | ||
| 04.12. | Lilly's Zepbound wins the weight loss duel with Novo's Wegovy | ||
| 04.12. | Maze Therapeutics raises $115m to advance kidney disease candidates | ||
| 04.12. | Ipsen and Biomunex enter agreement for cancer therapy | ||
| 04.12. | Takeda licensed for anaemia therapy by Keros Therapeutics | ||
| 03.12. | From Cobenfy to Emraclidine: the muscarinic path to safer antipsychotics | ||
| 03.12. | Lundbeck acquires all outstanding shares of Longboard Pharma | ||
| 03.12. | Novartis and Olema expand alliance with $250m to boost breast cancer trials | ||
| 03.12. | Navigating medicine pricing in Turkiye: the pharmaceutical Euro exchange rate | ||
| 03.12. | J&J's sBLAs seek FDA approval of TREMFYA for paediatric conditions | ||
| 03.12. | Novartis and PTC Therapeutics link to develop Huntington's therapy | ||
| 02.12. | Fate Therapeutics makes Bob Valamehr president and CEO | ||
| 02.12. | CHMP recommends oral peanut allergy immunotherapy treatment for toddlers | ||
| 02.12. | CBC acquires UCB's neurology and allergy business in China | ||
| 02.12. | UQ secures funds for development of skin cancer prevention cream | ||
| 29.11. | EMA launches ESMP for better management of drug shortages in EU | ||
| 29.11. | University of Birmingham identifies target to reduce GVHD risk | ||
| 29.11. | UK Government to launch first ever men's health strategy | ||
| 29.11. | UK reports near eradication of meningitis C amid declining vaccine uptake |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
